Shine and darkle the blood vessels: Multiparameter hypersensitive MR angiography for diagnosis of panvascular diseases.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39365870.
- Also identified by DOI 10.1126/sciadv.adq4082 and PMC identifier 11451532.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Magnetic resonance angiography (MRA) is pivotal for diagnosing panvascular diseases. However, single-modality MRA falls short in diagnosing diverse vascular abnormalities. Thus, contrast agents combining <i>T</i><sub>1</sub> and <i>T</i><sub>2</sub> effects are sought for multiparameter MRA with clinical promise, yet achieving a balance in <i>T</i><sub>1</sub> and <i>T</i><sub>2</sub> contrast enhancement effects remains a scientific challenge. Herein, we developed a hypersensitive multiparameter MRA strategy using dual-modality NaGdF<sub>4</sub> nanoparticles. Because of the longer tumbling time (τ<sub>R</sub>), NaGdF<sub>4</sub> nanoparticles can improve the longitudinal relaxivity (<i>r</i><sub>1</sub>), brightening vessels in <i>T</i><sub>1</sub>-weighted sequences. Simultaneously, the regular arrangement of Gd<sup>3+</sup> in the crystal induces magnetic anisotropy, creating local static magnetic field heterogeneity and generating negative signals in <i>T</i><sub>2</sub>-weighted sequences. Consequently, the efficacy of NaGdF<sub>4</sub>-enhanced high-resolution multiparameter MRA has been validated in diagnosing ischemic stroke and Alzheimer's disease in rodent models. In addition, the dual-contrast imaging has been realized on swine with a clinical 3.0-T magnetic resonance imaging scanner, highly emphasizing the clinical translation prospect.
Medical subject headings
- Magnetic Resonance Angiography
- Contrast Media